Vorinostat Terminated Phase 1 Trials for Recurrent Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity / Stage IV Squamous Cell Carcinoma of the Hypopharynx / Salivary Gland Squamous Cell Carcinoma / Stage IV Non-Small Cell Lung Cancer / Recurrent Squamous Cell Carcinoma of the Larynx / Stage IV Breast Cancer / Stage IV Squamous Cell Carcinoma of the Nasopharynx / Stage IV Esophageal Cancer / Stage IV Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity / Stage IV Squamous Cell Carcinoma of the Oropharynx / Recurrent Metastatic Squamous Neck Cancer With Occult Primary / Recurrent Squamous Cell Carcinoma of the Lip and Oral Cavity / Stage IV Salivary Gland Cancer / Stage IV Verrucous Carcinoma of the Larynx / Recurrent Breast Cancer / Stage IV Squamous Cell Carcinoma of the Larynx / Recurrent Gastric Cancer / Advanced Gastric Cancer / Unspecified Adult Solid Tumor, Protocol Specific / Recurrent Salivary Gland Cancer / Human Immunodeficiency Virus (HIV) Infections / Stage IV Ovarian Epithelial Cancer / Recurrent Ovarian Epithelial Cancer / Stage IV Verrucous Carcinoma of the Oral Cavity / Non-Small Cell Lung Cancer Recurrent / Stage IV Anal Cancer / Recurrent Verrucous Carcinoma of the Larynx / Recurrent Squamous Cell Carcinoma of the Nasopharynx / Recurrent Anal Cancer / Stage IV Squamous Cell Carcinoma of the Lip and Oral Cavity / Recurrent Squamous Cell Carcinoma of the Hypopharynx / Recurrent Esophageal Cancer / Recurrent Verrucous Carcinoma of the Oral Cavity / Recurrent Squamous Cell Carcinoma of the Oropharynx Treatment

IndicationsStatusPurposePhase
TerminatedTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT01249443Paclitaxel and Carboplatin in Treating Patients With Metastatic or Recurrent Solid Tumors and HIV Infection